| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 68 | 92 | 77 | 95 | 75 | 89 | 99 | 84 | 191 | 146 | 128 | 135 | 132 | 205 | 126 | 145 | 145 | 142 | 121 | 159 | 97 | 171 | 146 | 199 | 110 | 178 | 189 | 202 | 141 | 195 |
| Expenses | 57 | 72 | 71 | 98 | 64 | 75 | 86 | 84 | 177 | 115 | 104 | 107 | 113 | 175 | 112 | 137 | 129 | 127 | 109 | 131 | 85 | 150 | 131 | 176 | 97 | 163 | 159 | 166 | 122 | 162 |
| EBITDA | 11 | 19 | 6 | -3 | 11 | 14 | 13 | 0 | 13 | 31 | 24 | 29 | 19 | 30 | 14 | 8 | 16 | 15 | 12 | 28 | 13 | 21 | 14 | 23 | 13 | 16 | 30 | 36 | 19 | 33 |
| Operating Profit % | 15 % | 18 % | 6 % | -8 % | 13 % | 14 % | 11 % | -2 % | 6 % | 8 % | 15 % | 4 % | 13 % | 13 % | 10 % | 4 % | 10 % | 9 % | 7 % | 16 % | 11 % | 11 % | 8 % | 10 % | 10 % | 4 % | 10 % | 15 % | 11 % | 16 % |
| Depreciation | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 7 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 8 | 8 | 9 | 7 | 8 | 8 | 6 | 7 | 6 | 6 | 6 | 5 | 5 | 6 | 6 |
| Interest | 8 | 11 | 10 | 0 | 6 | 5 | 4 | -2 | 3 | 7 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -6 | -0 | -12 | -12 | -4 | 1 | 0 | -5 | 2 | 15 | 14 | 18 | 10 | 22 | 5 | 0 | 8 | 6 | 5 | 20 | 5 | 14 | 8 | 18 | 7 | 9 | 25 | 31 | 13 | 27 |
| Tax | 0 | -1 | -1 | -0 | 0 | 0 | 1 | 1 | 0 | 2 | 2 | -17 | -2 | -2 | -1 | 0 | 1 | 0 | 1 | 9 | 4 | 4 | 1 | 7 | 6 | 6 | 5 | 10 | 3 | 6 |
| Net Profit | -6 | 0 | -12 | -12 | -4 | 0 | -1 | -5 | 2 | 13 | 12 | 35 | 12 | 23 | 6 | 0 | 7 | 5 | 3 | 11 | 1 | 10 | 7 | 11 | 1 | 4 | 20 | 21 | 10 | 20 |
| EPS in ₹ | -4.70 | 0.34 | -9.50 | -9.29 | -3.30 | 0.34 | -0.78 | -4.38 | 1.60 | 10.55 | 9.44 | 28.45 | 8.86 | 17.32 | 4.22 | 0.17 | 5.16 | 3.99 | 2.46 | 8.27 | 0.88 | 7.44 | 5.13 | 7.86 | 0.92 | 2.63 | 14.66 | 15.71 | 7.18 | 15.06 |
Venus Remedies
Venus Remedies
748.15
+35.05
(4.92%)
Market Cap
1,000.05 Cr
PE Ratio
13.81
Volume
15,688.00
Day High - Low
748.75 - 696.70
52W High-Low
839.90 - 270.25
Key Fundamentals
Market Cap
1,000.05 Cr
EPS
33.90
PE Ratio
13.81
PB Ratio
1.63
Book Value
444.61
EBITDA
84.50
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
8.08
Debt to Equity
0.04
Actual
Company News
View All News
Venus Remedies receives ₹11.77 crore under the PLI scheme, adding to its previous ₹10 crore disbursement, strengthening its pharmaceutical manufacturing capabilities.
Venus Remedies Limited has scheduled a board meeting on January 29, 2026, to consider and approve unaudited standalone and consolidated financial results for the quarter ended December 31, 2025.
Venus Remedies corrects UDIN for Q2FY26 results
Jan 13, 2026
Jan 13, 2026Venus Remedies Limited updates UDIN for consolidated financial results after clerical duplication error in statutory auditor reports for quarter ended September 30, 2025.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,638.90 | #1 3,93,227.01 | 37.34 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 32.48 | |
6,056.00 | 1,60,767.77 | 64.15 | 9,712.00 | 18.67 | 2,191 | 35.10 | 31.96 | |
3,997.40 | 1,35,290.18 | 62.11 | 11,539.40 | 6.99 | 1,911 | 30.46 | 51.26 | |
1,313.00 | 1,06,060.44 | 23.43 | 28,409.50 | 7.12 | 5,291 | -57.18 | 16.66 | |
1,239.80 | 1,03,477.47 | 18.67 | 33,741.20 | 16.73 | 5,725 | -15.28 | 53.53 | |
2,150.50 | 98,234.58 | 22.46 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 49.85 | |
893.35 | 89,891.91 | #1 17.65 | 23,511.00 | 18.55 | 4,615 | 34.60 | 39.82 | |
2,094.20 | 86,449.64 | 48.94 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 41.23 | |
5,754.00 | 68,797.70 | 28.50 | 13,458.30 | 3.70 | 2,216 | 10.98 | 54.24 | |
1,129.70 | 65,613.16 | 19.24 | 32,345.60 | 9.43 | 3,484 | 3.81 | 37.32 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
9.10 %
Net Income Growth
58.95 %
Cash Flow Change
131.80 %
ROE
38.36 %
ROCE
51.90 %
EBITDA Margin (Avg.)
8.79 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 841 | 843 | 765 | 751 | 733 | 644 | 556 | 580 | 601 | 627 | 716 |
| Fixed Assets | 444 | 453 | 406 | 389 | 364 | 289 | 262 | 241 | 216 | 219 | 229 |
| Current Assets | 233 | 277 | 259 | 260 | 265 | 294 | 234 | 278 | 323 | 360 | 452 |
| Capital Work in Progress | 78 | 80 | 66 | 65 | 65 | 25 | 25 | 25 | 26 | 21 | 26 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 | 19 | 84 |
| Other Assets | 319 | 310 | 293 | 297 | 304 | 330 | 269 | 314 | 339 | 368 | 376 |
| Total Liabilities | 841 | 843 | 765 | 751 | 733 | 644 | 556 | 580 | 601 | 627 | 716 |
| Current Liabilities | 163 | 193 | 197 | 230 | 264 | 225 | 97 | 93 | 83 | 79 | 136 |
| Non Current Liabilities | 222 | 212 | 180 | 159 | 137 | 96 | 58 | 47 | 58 | 60 | 19 |
| Total Equity | 457 | 438 | 389 | 362 | 333 | 323 | 400 | 440 | 460 | 488 | 561 |
| Reserve & Surplus | 445 | 426 | 376 | 350 | 320 | 311 | 374 | 427 | 447 | 474 | 548 |
| Share Capital | 11 | 11 | 12 | 12 | 12 | 12 | 12 | 13 | 13 | 13 | 13 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | 4 | -4 | 0 | -1 | -0 | 27 | 14 | -22 | 28 | 9 |
| Investing Activities | -67 | 3 | -18 | 9 | -11 | -5 | 57 | -17 | -58 | -9 | -77 |
| Operating Activities | 68 | 47 | 59 | 31 | 45 | 78 | 132 | 41 | 37 | 37 | 86 |
| Financing Activities | -1 | -46 | -44 | -39 | -35 | -73 | -162 | -10 | -1 | -1 | -1 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 35.89 % | 40.81 % | 40.81 % | 40.81 % | 40.81 % | 41.76 % | 41.76 % | 41.76 % | 41.76 % | 41.76 % | 41.76 % | 41.76 % | 41.76 % | 41.76 % | 41.76 % | 41.76 % | 41.76 % | 41.76 % | 41.76 % | 41.76 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 1.03 % | 1.59 % | 1.48 % | 1.06 % | 1.18 % | 1.11 % | 1.34 % | 2.24 % | 1.86 % | 2.26 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.15 % | 0.15 % | 0.15 % | 0.15 % | 0.15 % | 0.15 % | 0.15 % | 0.15 % | 0.15 % | 0.00 % | 0.00 % | 0.11 % | 0.75 % | 1.03 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 54.71 % | 51.21 % | 51.95 % | 52.18 % | 51.72 % | 49.97 % | 50.18 % | 50.04 % | 49.24 % | 48.66 % | 48.20 % | 47.25 % | 46.89 % | 46.25 % | 45.31 % | 45.42 % | 46.81 % | 47.70 % | 45.30 % | 45.16 % |
| Others | 9.39 % | 7.98 % | 7.24 % | 7.01 % | 7.48 % | 8.27 % | 7.91 % | 8.05 % | 8.85 % | 9.43 % | 8.86 % | 9.24 % | 9.73 % | 10.78 % | 11.61 % | 11.71 % | 10.09 % | 8.19 % | 10.33 % | 9.80 % |
| No of Share Holders | 13,829 | 13,846 | 16,617 | 18,231 | 19,952 | 21,189 | 22,015 | 22,243 | 21,719 | 20,498 | 19,267 | 19,560 | 19,913 | 19,614 | 19,557 | 19,771 | 19,982 | 19,307 | 17,725 | 18,606 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 29 Jan 2026 |  Quarterly Result Announcement | NA | 29 Jan 2026 | 784.80 | 726.40 |
| 23 Sept 2024 |  Annual General Meeting | NA | 23 Sept 2024 | 339.15 | 342.30 |
| 29 Oct 2024 | Quarterly Result Announcement | NA | 29 Oct 2024 | 345.90 | 343.60 |
| 04 Feb 2025 | Quarterly Result Announcement | NA | 04 Feb 2025 | 294.10 | 288.35 |
| 26 May 2025 | Quarterly Result Announcement | NA | 26 May 2025 | 344.05 | 355.60 |
| 01 Aug 2025 | Quarterly Result Announcement | NA | 01 Aug 2025 | 540.15 | 524.40 |
| 22 Aug 2025 | Annual General Meeting | NA | 22 Aug 2025 | 431.95 | 494.60 |
| 10 Nov 2025 | Quarterly Result Announcement | NA | 10 Nov 2025 | 441.00 | 448.85 |
Announcements
Venus Remedies Awarded With Rs. 117750000 Incentive Under The PLI Scheme.5 days ago
5 days agoBoard Meeting Intimation for The Meeting Of Board Of Directors Is Scheduled To Be Held On 29Th January 2026.8 days ago
8 days agoUpdation On UIDN For Financial Results As On 30Th September 2025Jan 13, 2026
Jan 13, 2026Grant Of Marketing Authorisation In IndonesiaJan 08, 2026
Jan 08, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Copy Of Newspaper Notice Pertaining To Physical Transfer Of Shares.Dec 26, 2025
Dec 26, 2025Closure of Trading WindowDec 23, 2025
Dec 23, 2025Social Media Communication Regarding Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares Of Venus Remedies Limited.Dec 13, 2025
Dec 13, 2025Shares Re-Lodged For Transfer Cum Demat Pursuant To SEBI Circular No. SEBI/HO/MIRSD/MIRSD-Pod/P/CIR/2025/97 Dated July 2 2025 For The Period July 7 2025 To November 30 2025Dec 12, 2025
Dec 12, 2025Venus Remedies Marks Completion Of AMR Licensing Milestones With Final ?11 Crore PaymentDec 08, 2025
Dec 08, 2025Update On Resolution Of Income Tax Matters And Elimination Of Contingent Liability.Dec 01, 2025
Dec 01, 2025Social Media Communication Regarding Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares Of Venus Remedies LimitedNov 28, 2025
Nov 28, 2025Clarification On Movement In VolumeNov 20, 2025
Nov 20, 2025Clarification sought from Venus Remedies LtdNov 20, 2025
Nov 20, 2025Social Media Communication Regarding Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares Of Venus Remedies LimitedNov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2025
Nov 12, 2025Unaudited Financial Results As On 30Th September 2025Nov 10, 2025
Nov 10, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated 10Th November 2025Nov 10, 2025
Nov 10, 2025Social Media Communication Regarding Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares.Oct 28, 2025
Oct 28, 2025Board Meeting Intimation for Board Meeting Scheduled To Be Held On 10Th November 2025.Oct 27, 2025
Oct 27, 2025SEBI Circular - Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares - Monthly Report.Oct 18, 2025
Oct 18, 2025Social Media Communication Regarding Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares.Oct 10, 2025
Oct 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Oct 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 07, 2025
Oct 07, 2025Closure of Trading WindowSep 22, 2025
Sep 22, 2025Social Media CommunicationSep 20, 2025
Sep 20, 2025Social Media Post On Saksham Niveshak Campaign By IEPF.Sep 11, 2025
Sep 11, 2025Social Media Communication Regarding Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares Of Venus Remedies LimitedAug 27, 2025
Aug 27, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 23, 2025
Aug 23, 2025Special Window For Re-Lodgement Of Transfer Requests Of
Physical Shares - Report For July 2025Aug 23, 2025
Aug 23, 2025Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares - Report For July 2025Aug 23, 2025
Aug 23, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 22, 2025
Aug 22, 2025Social Media Post On Saksham Niveshak CampaignAug 21, 2025
Aug 21, 2025Social Medial Announcement.Aug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 03, 2025
Aug 03, 2025Unaudited Financial Results For The Quarter Ended On 30Th June 2025Aug 01, 2025
Aug 01, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated 1St August 2025.Aug 01, 2025
Aug 01, 2025Social Media Communication Regarding Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares Of Venus Remedies LimitedJul 29, 2025
Jul 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 26, 2025
Jul 26, 2025Reg. 34 (1) Annual Report.Jul 24, 2025
Jul 24, 2025Notice Of Annual General Meeting Dated 22Nd August 2025.Jul 24, 2025
Jul 24, 2025Board Meeting Intimation for Notice Of Board Meeting Dated 1St August 2025.Jul 22, 2025
Jul 22, 2025Update On Trading In Shares Of Venus Remedies Ltd.Jul 21, 2025
Jul 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 11, 2025
Jul 11, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated 8Th July 2025.Jul 08, 2025
Jul 08, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Jul 08, 2025Board Meeting Intimation for Notice Of Board Meeting To Be Held On 8Th July 2025Jun 27, 2025
Jun 27, 2025Closure of Trading WindowJun 24, 2025
Jun 24, 2025Closure of Trading WindowJun 24, 2025
Jun 24, 2025Technical Indicators
RSI(14)
Neutral 44.56
ATR(14)
Volatile 42.49
STOCH(9,6)
Neutral 51.00
STOCH RSI(14)
Neutral 30.67
MACD(12,26)
Bearish -5.93
ADX(14)
Weak Trend 17.20
UO(9)
Bearish 47.75
ROC(12)
Downtrend And Accelerating -4.36
WillR(14)
Neutral -74.22
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
